Liquid chromatographic method for the simultaneous determination of imipenem and sulbactam in mouse plasma

Journal of Chromatographic Science

Volumn 44, Issue 9, 2006, Pages 548-551

  Aparicio, Irene ^a   Bello, Miguel Angel ^a   Callejón, Manuel ^a   Jiménez, Juan Carlos ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749621125     PISSN: 00219665     EISSN: 00219665     Source Type: Journal    
DOI: 10.1093/chromsci/44.9.548     Document Type: Article

References (10)

1. F.D. Wang, M.L. Lin, W.S. Lee, and C.Y. Liu. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria. Int. J. Antimicrob. Agents 23: 590-95 (2004).
2. J.Y. Choi, Y. Soo Park, C.H. Cho, Y. Seon Park, S.Y. Shin, Y.G. Song, D. Yong, K. Lee, and J.M. Kim. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii. Clin. Microbiol. Infect. 10: 1098-1101 (2004).
3. M.E. Pachón-Ibáñez, F. Docobo-Pérez, M.E. Jiménez-Mejías, C. Pichardo, A. García-Curiel, and J. Pachón. Efficacy of rifampicin, imipenem and sulbactam in monotherapy and combination, in the experimental pneumonia caused by panresistant Acinetobacter baumannii. Clin. Microbiol. Infect. 11: 577 (2005).
4. L. Chun-Ming, L. Hwee-Kheng, L. Chang-Pan, and T. Hsiang-Kuang. Treatment of pan-drug resistant Acinetobacter baumannii. Scand. J. Infect. Dis. 37: 195-99 (2005).
5. C. Urban, S. Segal-Maurer, and J.J. Rahal. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis. 36: 1268-74 (2003).
6. M.L. Joly-Guillou. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11: 868-73 (2005).
7. C. Polson, P. Sarkar, B. Incledon, V. Raguvaran, and R. Grant. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J. Cromatogr. B 785: 263-75 (2003).
8. International Conference on Harmonization. Q2B: Validation of Analytical Procedures: Methodology. The European Agency for the Evaluation of Medicinal Products, Brussels, Belgium November 1996.
9. Food and Drug Administration. Guidance for Industry. Bioanalytical Method Validation. FDA, Washington, D.C., May 2001.
10. G.A. Shabir. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J. Chromatogr. A 987: 57-66 (2003).